The current state of imaging biomarker development and evaluation

Area of Science:

• Medical Imaging
• Biomarker Discovery
• Translational Research

Background:

• Biomarker research, especially in medical imaging, frequently fails to translate into clinically applicable tools.
• Understanding the distinct roles of diagnostic versus prognostic biomarkers is essential.
• Current research phases and their limitations hinder clinical utility.

Purpose of the Study:

• To elucidate reasons for the low clinical utility of imaging biomarker research.
• To outline critical factors for designing robust studies that facilitate biomarker translation.
• To emphasize the necessity of rigorous evaluation for clinical adoption.

Main Methods:

• This narrative review synthesizes existing literature on biomarker research and clinical translation.
• Key considerations for study design, including statistical power and event numbers, are discussed.
• Methods for evaluating the incremental clinical benefit of novel biomarkers are examined.

Main Results:

• A significant gap exists between biomarker discovery and clinical implementation.
• Inadequate study design and insufficient rigorous evaluation contribute to research failures.
• Balancing the number of biomarkers with patient events is vital to mitigate false positives.

Conclusions:

• Translating imaging biomarkers requires meticulous study design, focusing on statistical rigor and clinical relevance.
• Thorough evaluation, including comparison with existing clinical tools, is necessary to demonstrate incremental benefit.
• Adopting these principles can improve the success rate of biomarker research in clinical practice.